{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T20:30:46Z","timestamp":1719779446558},"reference-count":63,"publisher":"Walter de Gruyter GmbH","issue":"2","license":[{"start":{"date-parts":[[2016,8,31]],"date-time":"2016-08-31T00:00:00Z","timestamp":1472601600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch. Immunol. Ther. Exp."],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1007\/s00005-016-0417-7","type":"journal-article","created":{"date-parts":[[2016,9,2]],"date-time":"2016-09-02T22:46:31Z","timestamp":1472856391000},"page":"137-143","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Autoreactive IgE in Chronic Spontaneous\/Idiopathic Urticaria and Basophil\/Mastocyte Priming Phenomenon, as a Feature of Autoimmune Nature of the Syndrome"],"prefix":"10.2478","volume":"65","author":[{"given":"Bernard","family":"Panaszek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Paw\u0142owicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u0119drzej","family":"Grzegrz\u00f3\u0142ka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrzej","family":"Obojski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2016,8,31]]},"reference":[{"key":"417_CR1","doi-asserted-by":"crossref","first-page":"e14794","DOI":"10.1371\/journal.pone.0014794","volume":"6","author":"S Altrichter","year":"2011","unstructured":"Altrichter S, Peter HJ, Pisarevskaja D et al (2011) IgE mediated autoallergy against thyroid peroxidase\u2014a novel pathomechanism of chronic spontaneous urticaria? PLoS One 6:e14794","journal-title":"PLoS One"},{"key":"417_CR2","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S1074-7613(01)00157-1","volume":"14","author":"K Asai","year":"2001","unstructured":"Asai K, Kitaura J, Kawakami Y et al (2001) Regulation of mast cell survival by IgE. Immunity 14:791\u2013800","journal-title":"Immunity"},{"key":"417_CR3","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1067\/mai.2003.1389","volume":"111","author":"R Asero","year":"2003","unstructured":"Asero R, Lorini M, Tedeschi A (2003) Association of chronic urticaria with thyroid autoimmunity and Raynaud phenomenon with anticentromere antibodies. J Allergy Clin Immunol 111:1129\u20131130","journal-title":"J Allergy Clin Immunol"},{"key":"417_CR4","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.jaci.2004.12.009","volume":"115","author":"R Asero","year":"2005","unstructured":"Asero R, Orsatti A, Tedeschi A et al (2005) Autoimmune chronic urticaria associated with type 1 diabetes and Graves disease. J Allergy Clin Immunol 115:1088\u20131089","journal-title":"J Allergy Clin Immunol"},{"key":"417_CR5","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1684\/ejd.2011.1285","volume":"21","author":"F Augey","year":"2011","unstructured":"Augey F, Gunera-Saad N, Bensaid B et al (2011) Chronic spontaneous urticaria is not an allergic disease. Eur J Dermatol 21:349\u2013353","journal-title":"Eur J Dermatol"},{"key":"417_CR6","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1365-2230.2005.02039.x","volume":"31","author":"K Aydogan","year":"2006","unstructured":"Aydogan K, Karadogan SK, Akdag I et al (2006) HLA class I and class II antigens in Turkish patients with chronic ordinary urticaria. Clin Exp Dermatol 31:424\u2013429","journal-title":"Clin Exp Dermatol"},{"key":"417_CR7","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/S0091-6749(99)70204-6","volume":"103","author":"S Bar-Sela","year":"1999","unstructured":"Bar-Sela S, Reshef T, Mekori YA (1999) IgE antithyroid microsomal antibodies in a patient with chronic urticaria. J Allergy Clin Immunol 103:1216\u20131217","journal-title":"J Allergy Clin Immunol"},{"key":"417_CR8","doi-asserted-by":"crossref","first-page":"433","DOI":"10.2500\/aap.2008.29.3148","volume":"29","author":"M Boguniewicz","year":"2008","unstructured":"Boguniewicz M (2008) The autoimmune nature of chronic urticaria. Allergy Asthma Proc 29:433\u2013438","journal-title":"Allergy Asthma Proc"},{"key":"417_CR9","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1111\/j.1398-9995.2011.02704.x","volume":"66","author":"F Bossi","year":"2011","unstructured":"Bossi F, Frossi B, Radillo O (2011) Mast cells are critically involved in serum-mediated vascular leakage in chronic urticaria beyond high-affinity IgE receptor stimulation. Allergy 66:1538\u20131545","journal-title":"Allergy"},{"key":"417_CR10","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2174\/1871528111312010002","volume":"12","author":"Z Calamita","year":"2013","unstructured":"Calamita Z, Pel\u00e1 Calamita AB (2013) Chronic spontaneous urticaria: epidemiological characteristics focusing on the histocompatibility profile and presence of antibodies. Inflamm Allergy Drug Targets 12:8\u201311","journal-title":"Inflamm Allergy Drug Targets"},{"key":"417_CR11","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1399-3038.2005.00309.x","volume":"16","author":"L Caminiti","year":"2005","unstructured":"Caminiti L, Passalacqua G, Magazzu G et al (2005) Chronic urticaria and associated celiac disease in children: a case-control study. Pediatr Allergy Immunol 16:428\u2013432","journal-title":"Pediatr Allergy Immunol"},{"key":"417_CR12","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1080\/00015550410026939","volume":"84","author":"M Caproni","year":"2004","unstructured":"Caproni M, Volpi W, Giomi B et al (2004) Chronic idiopathic and chronic autoimmune urticaria: clinical and immunopathological features of 68 subjects. Acta Derm Venereol 84:288\u2013290","journal-title":"Acta Derm Venereol"},{"key":"417_CR13","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jaci.2014.04.036","volume":"135","author":"TW Chang","year":"2015","unstructured":"Chang TW, Chen C, Lin CJ et al (2015) The potential pharmacologic mechanisms of omalizumab in patients with chronic spontaneous urticaria. J Allergy Clin Immunol 135:337\u2013342","journal-title":"J Allergy Clin Immunol"},{"key":"417_CR14","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s11882-011-0216-5","volume":"11","author":"N Charles","year":"2011","unstructured":"Charles N, Rivera J (2011) Basophils and autoreactive IgE in the pathogenesis of systemic lupus erythematosus. Curr Allergy Asthma Rep 11:378\u2013387","journal-title":"Curr Allergy Asthma Rep"},{"key":"417_CR15","first-page":"293","volume":"25","author":"LB Concha","year":"2004","unstructured":"Concha LB, Chang CC, Szema AM et al (2004) IgE antithyroid antibodies in patients with Hashimoto\u2019s disease and chronic urticaria. Allergy Asthma Proc 25:293\u2013296","journal-title":"Allergy Asthma Proc"},{"key":"417_CR16","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.jaci.2012.01.043","volume":"129","author":"R Confino-Cohen","year":"2012","unstructured":"Confino-Cohen R, Chodick G, Shalev V et al (2012) Chronic urticaria and autoimmunity: associations found in a large population study. J Allergy Clin Immunol 129:1307\u20131313","journal-title":"J Allergy Clin Immunol"},{"key":"417_CR17","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jaci.2005.04.042","volume":"116","author":"A Swerdt De","year":"2005","unstructured":"De Swerdt A, Van Den Keybus C, Kasran A et al (2005) Detection of basophil-activating IgG autoantibodies in chronic idiopathic urticaria by induction of CD 63. J Allergy Clin Immunol 116:662\u2013667","journal-title":"J Allergy Clin Immunol"},{"key":"417_CR18","doi-asserted-by":"crossref","first-page":"e90424","DOI":"10.1371\/journal.pone.0090424","volume":"9","author":"B Dema","year":"2014","unstructured":"Dema B, Pellefigues C, Hasni S et al (2014) Autoreactive IgE is prevalent in systemic lupus erythematosus and is associated with increased disease activity and nephritis. PLoS One 9:e90424","journal-title":"PLoS One"},{"key":"417_CR19","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/j.1365-2230.2009.03694.x","volume":"35","author":"A Frezzolini","year":"2010","unstructured":"Frezzolini A, Cadoni S, De Pit\u00e0 O (2010) Usefulness of the CD63 basophil activation test in detecting Anisakis hypersensitivity in patients with chronic urticaria: diagnosis and follow-up. Clin Exp Dermatol 35:765\u2013770","journal-title":"Clin Exp Dermatol"},{"key":"417_CR20","first-page":"311","volume-title":"Advances in dermatology","author":"CE Grattan","year":"2000","unstructured":"Grattan CE, Francis DM (2000) Autoimmune Urticaria. In: James WD, Cockerell CJ, Dzubow LM et al (eds) Advances in dermatology. Mosby Inc, St Louis, pp 311\u2013400"},{"key":"417_CR21","first-page":"272","volume":"13","author":"CE Grattan","year":"1995","unstructured":"Grattan CE, D\u2019Cruz DP, Francis DM et al (1995) Antiendothelial cell antibodies in chronic urticaria. Clin Exp Rheumatol 13:272\u2013273","journal-title":"Clin Exp Rheumatol"},{"key":"417_CR22","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/00130832-200310000-00008","volume":"3","author":"MW Greaves","year":"2003","unstructured":"Greaves MW (2003) Chronic idiopathic urticaria. Curr Opin Allergy Clin Immunol 3:363\u2013368","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"417_CR23","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/1523-1747.ep12462239","volume":"90","author":"BL Gruber","year":"1988","unstructured":"Gruber BL, Baeza ML, Marchese MJ et al (1988) Prevalence and functional role of anti-IgE autoantibodies in urticarial syndromes. J Invest Dermatol 90:213\u2013217","journal-title":"J Invest Dermatol"},{"issue":"Suppl 2","key":"417_CR24","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000350388","volume":"161","author":"Y Hatada","year":"2013","unstructured":"Hatada Y, Kashiwakura J, Hayama K et al (2013) Significantly high levels of anti-dsDNA immunoglobulin E in sera and the ability of dsDNA to induce the degranulation of basophils from chronic urticaria patients. Int Arch Allergy Immunol 161(Suppl 2):154\u2013158","journal-title":"Int Arch Allergy Immunol"},{"key":"417_CR25","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1056\/NEJM199306033282204","volume":"328","author":"M Hide","year":"1993","unstructured":"Hide M, Francis DM, Grattan CE et al (1993) Autoantibodies against the high affinity IgE receptor as a cause for histamine release in chronic urticaria. N Engl J Med 328:1599\u20131604","journal-title":"N Engl J Med"},{"key":"417_CR26","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1096\/fj.00-0890hyp","volume":"15","author":"MP Horn","year":"2001","unstructured":"Horn MP, Pachlopnik JM, Vogel M et al (2001) Conditional autoimmunity mediated by human natural anti-Fc(epsilon)RIalpha autoantibodies? FASEB J 15:2268\u20132274","journal-title":"FASEB J"},{"key":"417_CR27","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jdermsci.2007.08.008","volume":"49","author":"N Ishiura","year":"2008","unstructured":"Ishiura N, Fujimoto M, Watanabe R et al (2008) Serum levels of IgE anti-BP180 and anti-BP230 autoantibodies in patients with bullous pemphigoid. J Dermatol Sci 49:153\u2013161","journal-title":"J Dermatol Sci"},{"key":"417_CR28","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/1471-2164-7-210","volume":"7","author":"M Jayapal","year":"2006","unstructured":"Jayapal M, Tay HK, Reghunathan R et al (2006) Genomewide gene expression profiling of human mast cells stimulated by IgE or FcepsilonRI-aggregation reveals a complex network of genes involved in inflammatory responses. BMC Genom 7:210","journal-title":"BMC Genom"},{"key":"417_CR29","doi-asserted-by":"crossref","first-page":"9","DOI":"10.7762\/cnr.2014.3.1.9","volume":"3","author":"MG Kang","year":"2014","unstructured":"Kang MG, Song WJ, Park HK et al (2014) Basophil activation test with food additives in chronic urticaria patients. Clin Nutr Res 3:9\u201316","journal-title":"Clin Nutr Res"},{"key":"417_CR30","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jaci.2013.05.013","volume":"132","author":"A Kaplan","year":"2013","unstructured":"Kaplan A, Ledford D, Ashby M et al (2013) Omalizumab in patients with symptomatic chronic idiopathic\/spontaneous urticaria despite standard combination therapy. J Allergy Clin Immunol 132:101\u2013119","journal-title":"J Allergy Clin Immunol"},{"key":"417_CR31","doi-asserted-by":"crossref","first-page":"12911","DOI":"10.1073\/pnas.1735525100","volume":"100","author":"J Kitaura","year":"2003","unstructured":"Kitaura J, Song J, Tsai M et al (2003) Evidence that IgE molecules mediate a spectrum of effects on mast cell survival and activation via aggregation of the FcepsilonRI. Proc Natl Acad Sci USA 100:12911\u201312916","journal-title":"Proc Natl Acad Sci USA"},{"key":"417_CR32","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1111\/j.1398-9995.2009.02132.x","volume":"64","author":"GN Konstantinou","year":"2009","unstructured":"Konstantinou GN, Asero R, Maurer M et al (2009) EAACI\/GA2LEN task force consensus report: the autologous serum skin test in urticaria. Allergy 64:1256\u20131268","journal-title":"Allergy"},{"key":"417_CR33","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/all.12056","volume":"68","author":"GN Konstantinou","year":"2013","unstructured":"Konstantinou GN, Asero R, Ferrer M et al (2013) EAACI taskforce position paper: evidence for autoimmune urticaria and proposal for defining diagnostic criteria. Allergy 68:27\u201336","journal-title":"Allergy"},{"key":"417_CR34","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00005-006-0049-4","volume":"54","author":"A Kope\u0107","year":"2006","unstructured":"Kope\u0107 A, Panaszek B, Fal AM (2006) Intracellular signaling pathways in IgE-dependent mast cell activation. Arch Immunol Ther Exp 54:393\u2013401","journal-title":"Arch Immunol Ther Exp"},{"key":"417_CR35","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1189\/jlb.0212091","volume":"92","author":"J Lee","year":"2012","unstructured":"Lee J, Veatch SL, Baird B et al (2012) Molecular mechanisms of spontaneous and directed mast cell motility. J Leukoc Biol 92:1029\u20131041","journal-title":"J Leukoc Biol"},{"key":"417_CR36","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/j.1365-2133.2008.08499.x","volume":"158","author":"FD Louren\u00e7o","year":"2008","unstructured":"Louren\u00e7o FD, Azor MH, Santos JC et al (2008) Activated status of basophils in chronic urticaria leads to interleukin-3 hyper-responsiveness and enhancement of histamine release induced by anti-IgE stimulus. Br J Dermatol 158:979\u2013986","journal-title":"Br J Dermatol"},{"key":"417_CR37","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1365-2222.2005.02212.x","volume":"35","author":"E Luquin","year":"2005","unstructured":"Luquin E, Kaplan AP, Ferrer M (2005) Increased responsiveness of basophils of patients with chronic urticaria to sera but hypo-responsiveness to other stimuli. Clin Exp Allergy 35:456\u2013460","journal-title":"Clin Exp Allergy"},{"key":"417_CR38","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/ACI.0000000000000096","volume":"14","author":"MP Makris","year":"2014","unstructured":"Makris MP, Papadavid E, Zuberbier T (2014) The use of biologicals in cutaneous allergies\u2014present and future. Curr Opin Allergy Clin Immunol 14:409\u2013416","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"417_CR39","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.jaci.2005.08.042","volume":"116","author":"K Matsuda","year":"2005","unstructured":"Matsuda K, Piliponsky AM, Iikura M et al (2005) Monomeric IgE enhances human mast cell chemokine production: IL-4 augments and dexamethasone suppresses the response. J Allergy Clin Immunol 116:1357\u20131363","journal-title":"J Allergy Clin Immunol"},{"key":"417_CR40","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/s00105-004-0692-9","volume":"55","author":"M Maurer","year":"2004","unstructured":"Maurer M, Metz M, Magerl M et al (2004) Autoreaktive urtikaria und autoimmunurtikaria. Hautarzt 55:350\u2013356","journal-title":"Hautarzt"},{"key":"417_CR41","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jaci.2011.04.038","volume":"128","author":"M Maurer","year":"2011","unstructured":"Maurer M, Altrichter S, Bieber T et al (2011) Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyreoperoxidase. J. Allergy Clin Immunol 128:202\u2013209","journal-title":"J. Allergy Clin Immunol"},{"key":"417_CR42","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1056\/NEJMoa1215372","volume":"368","author":"M Maurer","year":"2013","unstructured":"Maurer M, Ros\u00e9n K, Hsieh HJ et al (2013) Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria. N Engl J Med 368:924\u2013935","journal-title":"N Engl J Med"},{"key":"417_CR43","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3233\/HAB-2001-103-404","volume":"10","author":"SM Miescher","year":"2001","unstructured":"Miescher SM, Horn MP, Pachlopnik JM et al (2001) Natural anti-FcepsilonRIalpha autoantibodies isolated from healthy donors and chronic idiopathic urticaria patients reveal a restricted repertoire and autoreactivity on human basophils. Hum Antibodies 10:119\u2013126","journal-title":"Hum Antibodies"},{"key":"417_CR44","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1046\/j.0307-6938.2001.00962.x","volume":"27","author":"E Nettis","year":"2002","unstructured":"Nettis E, Dambra P, D\u2019Oronzio L et al (2002) Reactivity to autologous serum skin test and clinical features in chronic idiopathic urticaria. Clin Exp Dermatol 27:29\u201331","journal-title":"Clin Exp Dermatol"},{"key":"417_CR45","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1046\/j.1365-2133.1999.02815.x","volume":"140","author":"BF O\u2019Donnell","year":"1999","unstructured":"O\u2019Donnell BF, O Neill CM, Francis DM et al (1999) Human leucocyte antigen class II associations in chronic idiopathic urticaria. Br J Dermatol 140:853\u2013858","journal-title":"Br J Dermatol"},{"key":"417_CR46","doi-asserted-by":"crossref","first-page":"392","DOI":"10.3349\/ymj.2004.45.3.392","volume":"45","author":"P Oztas","year":"2004","unstructured":"Oztas P, Onder M, Gonen S et al (2004) Is there any relationship between human leucocyte antigen class II and chronic urticaria? (chronic urticaria and HLA class II). Yonsei Med J 45:392\u2013395","journal-title":"Yonsei Med J"},{"key":"417_CR47","first-page":"107","volume":"15","author":"B Panaszek","year":"2006","unstructured":"Panaszek B, Basinska M (2006) The role of complement system, kinin system, coagulation system and fibrinolysis system in the pathogenesis of urticaria and angioedema. Adv Clin Exp Med 15:107\u2013112","journal-title":"Adv Clin Exp Med"},{"key":"417_CR48","first-page":"245","volume":"86C","author":"H Permin","year":"1978","unstructured":"Permin H, Wiik A (1978) The prevalence of IgE antinuclear antibodies in rheumatoid arthritis and systemic lupus erythematosus. Acta Pathol Microbiol Scand C 86C:245\u2013249","journal-title":"Acta Pathol Microbiol Scand C"},{"key":"417_CR49","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1111\/j.1365-2222.2005.02380.x","volume":"35","author":"A Puccetti","year":"2005","unstructured":"Puccetti A, Bason C, Simeoni S et al (2005) In chronic idiopathic urticaria autoantibodies against Fc epsilonRII\/CD23 induce histamine release via eosinophil activation. Clin Exp Allergy 35:1599\u20131607","journal-title":"Clin Exp Allergy"},{"key":"417_CR50","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1398-9995.1962.tb02937.x","volume":"17","author":"H Rorsman","year":"1962","unstructured":"Rorsman H (1962) Basophilic leucopenia in different forms of urticaria. Acta Allergol 17:168\u2013184","journal-title":"Acta Allergol"},{"key":"417_CR51","first-page":"16","volume":"11","author":"B Ryhal","year":"2001","unstructured":"Ryhal B, DeMera RS, Shoenfeld Y et al (2001) Are autoantibodies present in patients with subacute and chronic urticaria? J Investig Allergol Clin Immunol 11:16\u201320","journal-title":"J Investig Allergol Clin Immunol"},{"key":"417_CR52","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0190-9622(99)70495-0","volume":"40","author":"RA Sabroe","year":"1999","unstructured":"Sabroe RA, Seed PT, Francis DM et al (1999) Chronic idiopathic urticaria: comparison of the clinical features of patients with and without anti-FcepsilonRI or anti-IgE autoantibodies. J Am Acad Dermatol 40:443\u2013450","journal-title":"J Am Acad Dermatol"},{"key":"417_CR53","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1067\/mai.2002.126782","volume":"110","author":"RA Sabroe","year":"2002","unstructured":"Sabroe RA, Fiebiger E, Francis D et al (2002) Classification of anti-FcepsilonRI and anti-IgE autoantibodies in chronic idiopathic urticaria and correlation with disease severity. J Allergy Clin Immunol 110:492\u2013499","journal-title":"J Allergy Clin Immunol"},{"key":"417_CR54","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s11882-009-0040-3","volume":"9","author":"SS Saini","year":"2009","unstructured":"Saini SS (2009) Basophil responsiveness in chronic urticaria. Curr Allergy Asthma Rep 9:286\u2013290","journal-title":"Curr Allergy Asthma Rep"},{"key":"417_CR55","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/jid.2014.306","volume":"135","author":"SS Saini","year":"2015","unstructured":"Saini SS, Bindslev-Jensen C, Maurer M et al (2015) Efficacy and safety of omalizumab in patients with chronic idiopathic\/spontaneous urticaria who remain symptomatic on H1 antihistamines: a randomized, placebo-controlled study. J Invest Dermatol 135:67\u201375","journal-title":"J Invest Dermatol"},{"key":"417_CR56","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jaci.2012.05.039","volume":"130","author":"JH Savage","year":"2012","unstructured":"Savage JH, Courneya JP, Sterba PM et al (2012) Kinetics of mast cell, basophil, and oral food challenge responses in omalizumab-treated adults with peanut allergy. J Allergy Clin Immunol 130:1123\u20131129","journal-title":"J Allergy Clin Immunol"},{"key":"417_CR57","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000090656","volume":"212","author":"P Staubach","year":"2006","unstructured":"Staubach P, Onnen K, Vonend A et al (2006) Autologous whole blood injections to patients with chronic urticaria and a positive autologous serum skin test: aplacebo-controlled trial. Dermatology 212:150\u2013159","journal-title":"Dermatology"},{"key":"417_CR58","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1067\/mai.2001.117792","volume":"108","author":"A Tedeschi","year":"2001","unstructured":"Tedeschi A, Lorini M, Asero R (2001) Anti-thyroid peroxidase IgE in patients with chronic urticaria. J Allergy Clin Immunol 108:467\u2013468","journal-title":"J Allergy Clin Immunol"},{"key":"417_CR59","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4168\/aair.2015.7.3.205","volume":"7","author":"TE Twaroch","year":"2015","unstructured":"Twaroch TE, Curin M, Valenta R et al (2015) Mold allergens in respiratory allergy: from structure to therapy. Allergy Asthma Immunol Res 7:205\u2013220","journal-title":"Allergy Asthma Immunol Res"},{"key":"417_CR60","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2500\/105065800781329483","volume":"14","author":"DY Wang","year":"2000","unstructured":"Wang DY, Clement P (2000) Pathogenic mechanisms underlying the clinical symptoms of allergic rhinitis. Am J Rhinol 14:325\u2013333","journal-title":"Am J Rhinol"},{"key":"417_CR61","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.12659\/MSM.890137","volume":"20","author":"AD Yalcin","year":"2014","unstructured":"Yalcin AD (2014) An overview of the effects of anti-IgE therapies. Med Sci Monit 20:1691\u20131699","journal-title":"Med Sci Monit"},{"key":"417_CR62","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1034\/j.1398-9995.2000.00445.x","volume":"55","author":"T Zuberbier","year":"2000","unstructured":"Zuberbier T, Henz BM, Fiebiger E et al (2000) Anti-FcepsilonRIalpha serum autoantibodies in different subtypes of urticaria. Allergy 55:951\u2013954","journal-title":"Allergy"},{"key":"417_CR63","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/all.12313","volume":"69","author":"T Zuberbier","year":"2014","unstructured":"Zuberbier T, Aberer W, Asero R et al (2014) The EAACI\/GA(2) LEN\/EDF\/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. Allergy 69:868\u2013887","journal-title":"Allergy"}],"container-title":["Archivum Immunologiae et Therapiae Experimentalis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-016-0417-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00005-016-0417-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-016-0417-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-016-0417-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T20:48:50Z","timestamp":1704228530000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00005-016-0417-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,31]]},"references-count":63,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["417"],"URL":"https:\/\/doi.org\/10.1007\/s00005-016-0417-7","relation":{},"ISSN":["0004-069X","1661-4917"],"issn-type":[{"value":"0004-069X","type":"print"},{"value":"1661-4917","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,31]]}}}